Sponsors & Exhibitors

Platinum Sponsors

AbbVie is a global, research-driven biopharmaceutical company committed to developing innovative advanced therapies for some of the world's most complex and critical conditions. The company's mission is to use its expertise, dedicated people and unique approach to innovation to markedly improve treatments across four primary therapeutic areas: immunology, oncology, virology and neuroscience. In more than 75 countries, AbbVie employees are working every day to advance health solutions for people around the world. For more information about AbbVie, please visit us at www.abbvie.com. Follow @abbvie on Twitter, Facebook or LinkedIn.
Lilly is a global healthcare leader that unites caring with discovery to make life better for people around the world. We were founded more than a century ago by a man committed to creating high-quality medicines that meet real needs, and today we remain true to that mission in all our work. Across the globe, Lilly employees work to discover and bring life-changing medicines to those who need them, improve the understanding and management of disease, and give back to communities through philanthropy and volunteerism. To learn more about Lilly, please visit us at www.lilly.com and newsroom.lilly.com/social-channels.
Pfizer Inc.: Working together for a healthier world®
At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives. We strive to set the standard for quality, safety and value in the discovery, development and manufacture of health care products.
Regeneron Pharmaceuticals is a leading biotechnology company that invents life-transforming medicines for people with serious diseases. Sanofi is dedicated to supporting people through their health challenges. We are a global biopharmaceutical company focused on human health. Since 2007, Sanofi & Regeneron have collaborated to develop & commercialize fully human monoclonal antibodies utilizing proprietary technologies.

Gold Sponsors

Dermira, Inc. is a biopharmaceutical company dedicated to bringing biotech ingenuity to medical dermatology. The company is focused on delivering new therapies to the millions of patients living with chronic skin conditions. Dermira is committed to understanding and addressing the needs of both patients and physicians. The company will use its experience and insights to identify and develop leading-edge medical dermatology clinical programs. Dermira’s goal is to help transform the way skin conditions are treated by serving as the bridge between unmet patient needs and the significant scientific advances being made in understanding skin biology. Learn more at dermira.com.
Incyte Corporation is a biopharmaceutical company focused on the discovery, development, and commercialization of novel medicines to meet serious unmet medical needs in cancer and other diseases. Incyte is committed to the rigorous pursuit of R&D excellence to improve the lives of patients, make a difference in health care, and build sustainable value.

The Company strives to discover and develop first-in-class and best-in-class medicines—advancing a diverse portfolio comprised of 17 development candidates against 14 different molecular targets.

Headquartered in Wilmington, Delaware, Incyte has offices in Switzerland, nine other European countries and Japan. For more information, visit www.incyte.com and follow @Incyte.
LEO Pharma helps people achieve healthy skin. The company is a leader in medical dermatology with a robust R&D pipeline, a wide range of therapies and a pioneering spirit.

Founded in 1908 and owned by the LEO Foundation, LEO Pharma has devoted decades of research and development to advance the science of dermatology, setting new standards of care for people with skin conditions.

LEO Pharma is headquartered in Denmark with a global team of 5,700 people, serving 80 million patients in 130 countries. In 2017, the company generated net sales of 1.4 billion euro.

Silver Sponsors

Dermavant is a clinical-stage biopharmaceutical company focused on inflammatory skin diseases and medical dermatologic conditions. Led by its rigorous science-driven process, Dermavant has developed a pipeline that spans a broad disease state range in medical dermatology, including product candidates with multiple potential indications. Dermavant’s goal is to improve patients’ lives by developing and commercializing innovative therapies.
monARC is revolutionizing how research is done by transforming the data generated during routine clinical care and daily living into evidence for developing new treatments and better healthcare for patients in need while reducing time and cost for life science companies and healthcare providers.



Asana BioSciences is a clinical-stage biopharmaceutical company focused on the discovery and development of novel targeted therapies in inflammation/immunology and oncology.

Asana’s proprietary portfolio comprises multiple drug candidates, both small molecules and biologics. Our lead asset, ASN002, is an oral dual JAK/SYK inhibitor in Phase 2b clinical development for patients with moderate to severe atopic dermatitis and has broad development potential in other immunological diseases. Our oncology leads are targeted therapies in early clinical development for patients with advanced or metastatic cancers, including melanoma, non-small cell lung cancer, colorectal cancer and other solid tumors.

Asana BioSciences was founded in 2014 and is based near Princeton, NJ.

Sponsorship Opportunities

Exhibitor Information

We anticipate attendance by more than 100 dermatology and allergy health care professionals from all over the United States. As an exhibitor, you will have an opportunity to discuss your products and services with atopic dermatitis experts and gain visibility.

Who Should Exhibit?

This conference would benefit any industry professionals who have an interest in and commitment to improving patient outcomes and furthering the progress of atopic dermatitis treatments. Download the prospectus above for more information.

Rules and Regulations

Attendee Lists
Attendee lists will be available 4 weeks prior to the conference.

Grantor Attendance Policy
Representatives of commercial supporters may attend an educational activity but may not engage in promotional activities while in the room where the CME activity takes place. No commercial promotional materials shall be displayed or distributed in the same room as the CME activity. Exhibits are permitted at the conference; however, they shall not influence nor interfere with the presentation of the CME activity.

Giveaways and Promotional Items
The conference requests compliance with all applicable industry, state, and federal regulatory and governmental agency guidelines (AMA, PhRMA, OIG, FDA, FCC, FTC, AdvaMed, etc.). Acceptable giveaways should primarily entail a benefit to patients, be related to the physician’s work, and not be of substantial value. Giveaways may only be distributed from the exhibitor’s booth and may not be mailed to attendees after the meeting or delivered to outside locations during the meeting. Prize contests, awards, drawings, raffles, or lotteries of any kind held at any time or place during the conference are not permitted. The conference, in its sole discretion, shall have the right to prohibit the distribution of any samples it deems objectionable or otherwise inappropriate.

Cancellation and Refund Policy
Full refunds (less $100 processing fee) are available if requested in writing at least one month prior to the date of the program. The conference is not responsible for “acts of god” such as inclement weather, delays in airline travel, or governmental restrictions on travel due to national emergencies. Refunds will not be made if participants are delayed or unable to attend because of these issues.

© 2018 Revolutionizing Atopic Dermatitis LLC. All Rights Reserved.